2nd ARDS Drug Development Summit 2022

Temi della conferenza
Acute Respiratory Distress Syndrome (ARDS) is a growing and concerning unmet medical need with no effective therapeutic, and a serious medical burden in a world with or without COVID-19. Bringing industry together to consolidate the last 18 months of clinical and translational data, the 2nd ARDS Drug Development Summit is the only translational conference for drug developers to leverage the large homogeneous populations of COVID ARDS.

Professional congress organizer (PCO)
Hanson Wade

Annotazioni
Speakers: Alistair Wheeler, Chief Medical Officer, BioMarck Pharmaceuticals, Alpha A. Fowler, Professor, Virginia University, Aurelia De Pauw, Senior Vice President - Clinical Programs and Medical Affairs, Tetra Bio-Pharma and more.

https://go.evvnt.com/1034443-1?pid=4832

Ms. Jessica Durston